Langerhans cell histiocytosis in children less than 2 years of age

Indian Pediatrics

Volumn 36, Issue 1, 1999, Pages 29-36

  Kumary, P Kusuma ^a   Priyakumari T ^b   Chellam, V G ^b   James, Francis V ^b   Nair, M Krishnan ^b  

^a GOVERNMENT MEDICAL COLLEGE   (India)

^b NONE

Author keywords

Chemotherapy; Langerhans cell histiocytosis

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN; MERCAPTOPURINE; METHOTREXATE; PREDNISOLONE; VINBLASTINE;

ARTICLE; BONE MARROW CELL; CELL PROLIFERATION; CHILD; CLONAL ANERGY; FEMALE; HISTIOCYTOSIS X; HUMAN; INFANT; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FUNCTION; LANGERHANS CELL; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PROGNOSIS; RISK BENEFIT ANALYSIS; SURVIVAL; TREATMENT OUTCOME;

AGE FACTORS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BONE MARROW DISEASES; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; LIVER DISEASES; LUNG DISEASES; MALE; PREDNISOLONE; PROGNOSIS; RECURRENCE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; VINBLASTINE;

EID: 0344628809     PISSN: 00196061     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Raney RB, D'Angio B. Langerhans cell histiocytosis: Experience at the Children's Hospital of Philadelphia 1970 - 1984. Med Pediatr Oncol 1989; 17: 20-28.
2. Matus Ridley M, Rarey RB, Thawerani H, Meadows AT. Histiocytosis in children: Pattern of disease and results of treatment. Med Pediatr Oncol 1983; 11: 99-105.
3. Ceci A, Terlizzi M, Colella R, Criuseppe L, Balducci D, Giammarco, et al. Langerhans cell histiocytosis in childhood: Results from the Italian Co-operative AIEOP - CNR Hx 83 study. Med Pediatr Oncol 1993; 21: 259-264.
4. Kusuma Kumary P. Rajeev Kumar S, James FV, Chellam VG, Krishnan Nair M, Warrier RP. Langerhans cell histiocytosis in children: Pattern of disease and treatment results in Kerala. Int J Pediatr Hematol Oncol 1996; 3: 297-303.
5. Lahey ME. Histiocytosis; A analysis of prognostic factors. Pediatrics 1975; 87: 184-189.
6. Starling KA. Chemotherapy of histocytosis. Am J Pediatr Hematol Oncol 1981; 3: 157-160.
7. 2 receptor - deficiency and successful treatment with thymic extract. N Engl J. Med 1981; 304: 146-153.
8. Nezeloff C. Histiocytosis X: A proliferative disorder of Langerhans cell system. Med Pediatr Oncol 1986; 14: 105-115.
9. Willman CL, Busque L, Griffith BB, Biaise E, et al. Langerhans cell histiocytosis - A clonal proliferative disease. A Engl J Med. 1994; 331: 154-160.
10. Rivera-Luna R, Alter Molchadsky N, Cardenas Cardes R, Martinez Guerra G. Langerhans cell histiocytosis in children under 2 years of age. Med Pediatr Oncol 1996; 26: 334-343.
11. Greenberger JS, Crocker AC, Vawter G, Jaffe N, Cassady JR. Results of treatment of 127 patients with systemic histiocytosis 1989; 60: 311-338.
12. McLelland J, Broadbent V, Yeomans E, Malone M, Pritchard J. Langerhans cell histiocytosis. The case for conservative treatment. Arch Dis child. 1990; 65: 301-303.
13. Egeler M, Jan de Kraker, Voute PA. Cytosine arabinoside, vincristine and prednisolone in the treatment of children with disseminated langerhans cell histiocytosis with organ dysfunction. Med Pediatr Oncol 1993; 21: 265-270.
14. Goyal A, Rani S, Singh T, Choudhury P, Dubey AP. Childhood histiocytoses: A review of 22 cases. Indian Pediatr 1998; 35: 151-156.
15. Boradbent V. Favorable prognostic features in histiocytosis X: Bone involvement and absence of skin disease. Arch Dis Child 1986; 61: 1219-1221.
16. Neuton WA, Hamoudi AB. A histologic classification with clinical correlation. In: Perspectives in pediatric pathology, vol, 1. Eds. Rosenberg HS, Bolande RP. Chicago, Year Book Publishers, 1973; pp 251-283.
17. Frederiksen P, Thommensen P. Histio-cytosis X - II. Histologic appearance correlated to prognosis and extent of disease. Acta Radiol Oncol 1978; 17: 10-16.
18. Gadner H, Heitger A, Grois N, Gatterer Menz I, Ladisch S for DALH X-83 study. Treatment strategy for disseminated Langerhans cell histiocytosis. Med Pediatr Oncol 1994; 23: 72-80.
19. Berry DH, Gresik MV, Humphrey GB, Starling K, Vietti T, Boyett S. et al. Natural history of Histiocytosis X: A Pediatric Oncology Group Study. Med Pediatr Oncol 1986; 14: 1-5.
20. Mahmoud HM, Wang WL, Murphy SB. Cyclosporine therapy for advanced Langerhans cell histiocytosis. Blood 1991; 77: 721-725.
21. Arico M, Colella R, Canter V, Idolfi P, Pession A. Cyclosporine therapy for refractony LCH. Med Pediatr Oncol 1995; 25: 12-16.